Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Foerde – page 3

88 clinical trials in Foerde, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Foerde at a glance
88
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

88 trials in Foerde

Open in trial search

Study Comparing Aspirin Alone to Aspirin and Fondaparinux in Patients with Non-ST-Elevation Myocardial Infarction (NSTEMI)

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Region Midtjylland

Study on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Dabrafenib
  • Sponsor:Oslo University Hospital HF

Renal failure

Recruiting

Study on Preventing Blood Infections in Hemodialysis Patients Using Amoxicillin/Clavulanic Acid or Clindamycin

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Region Sjaelland

Study on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Oslo University Hospital HF

Study on Fluid Removal Using Furosemide and Amiloride Hydrochloride in ICU Patients with Fluid Overload

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Furosemide
  • Sponsor:Rigshospitalet

Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Study on Omeprazole and Cow's Milk-Free Diet for Treating Gastroesophageal Reflux Disease in Infants Under 1 Year

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Omeprazole
  • Sponsor:Odense University Hospital

Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Karolinska Institutet

Study of Iberdomide and Isatuximab for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Universitaetsklinikum Heidelberg AöR

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Study on Lowering INR to Reduce Bleeding in Patients with Mechanical Aortic Valves Using Warfarin, Acenocoumarol, and Phenprocoumon

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acenocoumarol
  • Sponsor:Hamilton Health Sciences Corporation

Study on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Warfarin Sodium
  • Sponsor:Rigshospitalet

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Foerde

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on precision cancer medicine for rare and hard-to-treat cancers, including targeted therapy approaches and personalized treatment strategies.

  • Breast Cancer Molecular Studies
  • Advanced Non-Small Cell Lung Cancer
  • Multiple Myeloma Treatments

Studies aim to identify treatment response markers and evaluate novel therapeutic combinations.

02 Hematological Studies

Research focusing on blood disorders and blood-related cancers, with emphasis on developing treatment options for patients unsuitable for standard chemotherapy.

  • Acute Myeloid Leukemia
  • Multiple Myeloma
  • High-Risk Myelodysplastic Syndrome

Trials evaluate combination therapies and novel treatment approaches for better patient outcomes.

03 Neurological & Autoimmune Conditions

Studies examining new therapeutic approaches for multiple sclerosis and rheumatoid arthritis, focusing on drug monitoring and treatment optimization.

  • Multiple Sclerosis Management
  • Rheumatoid Arthritis Control
  • Drug Response Monitoring

Research aims to improve disease control and treatment effectiveness through proactive monitoring.

04 Specialized Medical Research

Diverse clinical investigations including studies on sudden hearing loss and pain management in cancer patients.

  • Hyperbaric Oxygen Therapy
  • Pain Management Studies
  • Therapeutic Drug Monitoring

Focus on improving treatment outcomes through innovative therapeutic approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.